Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NU-TOPIRAMATE DIN 02334321

Status: Cancelled (Unreturned Annual)
Holder: NU-PHARM INC
Molecule: TOPIRAMATE

Health Canada record

Active ingredient(s)TOPIRAMATE 50 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN03AX11 TOPIRAMATE
Original market date
Current status date28-Mar-2018
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TOPIRAMATE

DINProductCompanyFormStrengthStatus
02279614APO-TOPIRAMATEAPOTEX INCTabletTOPIRAMATE 25 MGMarketed
02279622APO-TOPIRAMATEAPOTEX INCTabletTOPIRAMATE 50 MGApproved
02279630APO-TOPIRAMATEAPOTEX INCTabletTOPIRAMATE 100 MGMarketed
02279649APO-TOPIRAMATEAPOTEX INCTabletTOPIRAMATE 200 MGMarketed
02345811AURO-TOPIRAMATEAURO PHARMA INCTabletTOPIRAMATE 50 MGApproved
02345803AURO-TOPIRAMATEAURO PHARMA INCTabletTOPIRAMATE 25 MGMarketed
02287773GLN-TOPIRAMATEGLENMARK PHARMACEUTICALS CANADA INC.TabletTOPIRAMATE 100 MGMarketed
02287781GLN-TOPIRAMATEGLENMARK PHARMACEUTICALS CANADA INC.TabletTOPIRAMATE 200 MGMarketed
02287765GLN-TOPIRAMATEGLENMARK PHARMACEUTICALS CANADA INC.TabletTOPIRAMATE 25 MGMarketed
02345269JAMP TOPIRAMATE TABLETSJAMP PHARMA CORPORATIONTabletTOPIRAMATE 100 MGMarketed
02345250JAMP TOPIRAMATE TABLETSJAMP PHARMA CORPORATIONTabletTOPIRAMATE 25 MGMarketed
02345277JAMP TOPIRAMATE TABLETSJAMP PHARMA CORPORATIONTabletTOPIRAMATE 200 MGMarketed
02315645MINT-TOPIRAMATEMINT PHARMACEUTICALS INCTabletTOPIRAMATE 25 MGMarketed
02315661MINT-TOPIRAMATEMINT PHARMACEUTICALS INCTabletTOPIRAMATE 200 MGMarketed
02315653MINT-TOPIRAMATEMINT PHARMACEUTICALS INCTabletTOPIRAMATE 100 MGMarketed
02263351MYLAN-TOPIRAMATEMYLAN PHARMACEUTICALS ULCTabletTOPIRAMATE 25 MGMarketed
02263378MYLAN-TOPIRAMATEMYLAN PHARMACEUTICALS ULCTabletTOPIRAMATE 100 MGMarketed
02263386MYLAN-TOPIRAMATEMYLAN PHARMACEUTICALS ULCTabletTOPIRAMATE 200 MGMarketed
02312085PMS-TOPIRAMATEPHARMASCIENCE INCTabletTOPIRAMATE 50 MGMarketed
02263017PMS-TOPIRAMATEPHARMASCIENCE INCTabletTOPIRAMATE 200 MGMarketed
02262991PMS-TOPIRAMATEPHARMASCIENCE INCTabletTOPIRAMATE 25 MGMarketed
02263009PMS-TOPIRAMATEPHARMASCIENCE INCTabletTOPIRAMATE 100 MGMarketed
02313650PRO-TOPIRAMATEPRO DOC LIMITEETabletTOPIRAMATE 25 MGMarketed
02313669PRO-TOPIRAMATEPRO DOC LIMITEETabletTOPIRAMATE 100 MGMarketed
02313677PRO-TOPIRAMATEPRO DOC LIMITEETabletTOPIRAMATE 200 MGMarketed
02248862TEVA-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 200 MGMarketed
02248860TEVA-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 25 MGMarketed
02248861TEVA-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 100 MGMarketed
02239907TOPAMAXJANSSEN INCCapsuleTOPIRAMATE 15 MGMarketed
02239908TOPAMAXJANSSEN INCCapsuleTOPIRAMATE 25 MGMarketed
02271168DOM-TOPIRAMATEDOMINION PHARMACALTabletTOPIRAMATE 100 MGCancelled Post Market
02271141DOM-TOPIRAMATEDOMINION PHARMACALTabletTOPIRAMATE 25 MGCancelled Post Market
02271176DOM-TOPIRAMATEDOMINION PHARMACALTabletTOPIRAMATE 200 MGCancelled Post Market
02334356NU-TOPIRAMATENU-PHARM INCTabletTOPIRAMATE 200 MGCancelled (Unreturned Annual)
02334348NU-TOPIRAMATENU-PHARM INCTabletTOPIRAMATE 100 MGCancelled (Unreturned Annual)
02334313NU-TOPIRAMATENU-PHARM INCTabletTOPIRAMATE 25 MGCancelled (Unreturned Annual)
02271192PHL-TOPIRAMATEPHARMEL INCTabletTOPIRAMATE 100 MGCancelled Post Market
02271206PHL-TOPIRAMATEPHARMEL INCTabletTOPIRAMATE 200 MGCancelled Post Market
02271184PHL-TOPIRAMATEPHARMEL INCTabletTOPIRAMATE 25 MGCancelled Post Market
02256843RATIO-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 200 MGCancelled Post Market
02256827RATIO-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 25 MGCancelled Post Market
02256835RATIO-TOPIRAMATETEVA CANADA LIMITEDTabletTOPIRAMATE 100 MGCancelled Post Market
02260069SANDOZ TOPIRAMATESANDOZ CANADA INCORPORATEDTabletTOPIRAMATE 100 MGCancelled Post Market
02260050SANDOZ TOPIRAMATESANDOZ CANADA INCORPORATEDTabletTOPIRAMATE 25 MGCancelled Post Market
02267837SANDOZ TOPIRAMATESANDOZ CANADA INCORPORATEDTabletTOPIRAMATE 200 MGCancelled Post Market
02231385TOPAMAXJANSSEN INCTabletTOPIRAMATE 50 MGCancelled Pre Market
02231387TOPAMAXJANSSEN INCTabletTOPIRAMATE 400 MGCancelled Pre Market
02231386TOPAMAXJANSSEN INCTabletTOPIRAMATE 300 MGCancelled Pre Market
02230894TOPAMAX 100MGJANSSEN INCTabletTOPIRAMATE 100 MGCancelled Post Market
02230896TOPAMAX 200MGJANSSEN INCTabletTOPIRAMATE 200 MGCancelled Post Market
02230893TOPAMAX 25MGJANSSEN INCTabletTOPIRAMATE 25 MGCancelled Post Market
02344874TOPIRAMATECOBALT PHARMACEUTICALS COMPANYTabletTOPIRAMATE 200 MGCancelled Pre Market
02344866TOPIRAMATECOBALT PHARMACEUTICALS COMPANYTabletTOPIRAMATE 100 MGCancelled Pre Market
02344858TOPIRAMATECOBALT PHARMACEUTICALS COMPANYTabletTOPIRAMATE 25 MGCancelled Pre Market
02345412TOPIRAMATEMELIAPHARM INCTabletTOPIRAMATE 25 MGCancelled Post Market
02345439TOPIRAMATEMELIAPHARM INCTabletTOPIRAMATE 100 MGCancelled Post Market
02345447TOPIRAMATEMELIAPHARM INCTabletTOPIRAMATE 200 MGCancelled Post Market
02325152ZYM-TOPIRAMATEZYMCAN PHARMACEUTICALS INCTabletTOPIRAMATE 200 MGCancelled Post Market
02325136ZYM-TOPIRAMATEZYMCAN PHARMACEUTICALS INCTabletTOPIRAMATE 25 MGCancelled Post Market
02325144ZYM-TOPIRAMATEZYMCAN PHARMACEUTICALS INCTabletTOPIRAMATE 100 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
106322009-10-04Abbreviated New Drug Submission (ANDS)New manufacturer and product name

International API supply for TOPIRAMATE

4 valid EDQM Certificates of Suitability from 4 holders. 20 active FDA Drug Master Files.

Request a quote for NU-TOPIRAMATE

How to read a Canadian DIN record